Systematic neonatal screening and carrier detection: Lessons from sickle cell disease and cystic fibrosis screening in france

Genomics and public health: Legal and socio-ethical perspectives

Volumn , Issue , 2006, Pages 67-78

  Dhondt, Jean Louis ^a  

^a Centre Hospitalier Saint Philibert GHICL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882400233     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1163/ej.9789004155596.i-329     Document Type: Chapter

References (20)

1. J. L. Dhondt et al., Neonatal Screening in France, 2 SCREENING 77 (1993).
2. J. L. Dhondt et al., Results of Pilot Screening Activities in the French Neonatal Screening-Cystic Fibrosis, Congenital Adrenal Hyperplasia and Sickle Cell Disease, 2 SCREENING 87 (1993).
3. J. P. Farriaux et al., Neonatal Screening for Cystic Fibrosis: France Rises to the Challenge, 26 J. INHER. MET. DIS. 729 (2003).
4. A. M. Comeau et al., Population-Based Newborn Screening for Genetic Disorders when Multiple Mutation DNA Testing is Incorporated: A Cystic Fibrosis Newborn Screening Model Demonstrating Increased Sensitivity but More Carrier Detections, 113 PEDIATRICS 1573 (2004).
5. K. G. Monaghan et al., Preconception and Prenatal Cystic Fibrosis Carrier Screening of African Americans Reveals Unanticipated Frequencies for Specific Mutations, 6 GENETMED. 41 (2004).
6. Law No. 78-17 of January 6, 1978, Journal Officiel de la République Française [J.O.] [Official Gazette of France], July 18, 1978.
7. Law No. 88-1138 of December 20, 1988, Journal Officiel de la République Française [J.O.] [Official Gazette of France], December 22, 1988.
8. Law No. 94-653 of July 29, 1994, Journal Officiel de la République Française [J.O.] [Official Gazette of France], July 30, 1994.
9. Law No. 94-654 of July 29, 1994, Journal Officiel de la République Française [J.O.] [Official Gazette of France], July 30, 1994.
10. Law No. 96- 452 of May 28, 1996, Journal Officiel de la République Française [J.O.] [Official Gazette of France], May 29, 1996.
11. Decree No. 2000-570 of June 23, 2000, Journal Officiel de la République Française [J.O.] [Official Gazette of France], June 27, 2000.
12. Law No. 2004-800 of August 6, 2004, Journal Officiel de la République Française [J.O.] [Official Gazette of France], August 7, 2004.
13. J. L. Dhondt & J. P. Farriaux, Impact of French Legislation on Neonatal Screening, in Human DNA: Law and Policy 285 (B. M. Knoppers ed., 1997).
14. Law No. 2004-800.
15. E. P. Parsons et al., Implications of Carrier Identification in Newborn Screening for Cystic Fibrosis, 88 ARCH. DIS. CHILD. FETAL NEONATAL ED. F467 (2003).
16. S. Oliver et al., Disclosing to Parents Newborn Carrier Status Identified by Routine Blood Spot Screening, 4 COCHRANE DATABASE SYST. REV. CD003859 (2004).
17. L. Laird et al., Neonatal Screening for Sickle Cell Disorders: What About the Carrier Infants? 313 B. M. J. 407 (1996).
18. M. De Montalembert et al., Ethical Aspects of Neonatal Screening for Sickle Cell Disease in Western European Countries, 94 ACTA PAEDIATR. 528 (2005).
19. J. Sarles et al., Combining Immunoreactive Trypsinogen and Pancreatitis-Associated Protein Assays. A Method of Newborn Screening for Cystic Fibrosis that Avoids DNA Analysis,147 J. PEDIATR. 302 (2005).
20. B. J. Rosenstein, What is a Cystic Fibrosis Diagnosis? 19 CLIN. CHEST. MED. 423 (1998).